David R. Epstein - Jul 13, 2022 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Mike Rhee, attorney-in-fact
Stock symbol
SNTI
Transactions as of
Jul 13, 2022
Transactions value $
$0
Form type
4
Date filed
7/15/2022, 06:00 PM
Previous filing
Jun 30, 2022
Next filing
Nov 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +125K $0.00 125K Jul 13, 2022 Common Stock 125K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission.

Remarks:

Exhibit 24 - Power of Attorney